Beta-adrenoreceptor blocking drugs and epicutaneous allergologic studies
Sillevis Smitt, J.H.; van Joost, T.
Nederlands Tijdschrift Voor Geneeskunde 125(1): 17-18
1981
ISSN/ISBN: 0028-2162 PMID: 6110192 Document Number: 170642
Document emailed within 1 workday
Related Documents
England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-401979: Adverse Drug Reactions Advisory Committee. Peyronie's disease. A complication in therapy with beta-adrenoreceptor blocking drugs? Medical Journal of Australia 2(8): 432
Moore, G.E.; O'Donnell, S.R. 1970: A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole Journal of Pharmacy and Pharmacology 22(3): 180-188
Buist, R.A.; Williams, L.R.; Cairncross, K.D. 1974: Pharmacology of sympathomimetic amines with beta-adrenoreceptor agonist and alpha-adrenoreceptor antagonist properties Archives Internationales de Pharmacodynamie et de Therapie 209(2): 227-236
Imai, S. 1975: Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs Nihon Jinzo Gakkai Shi 17(7): 674-677
Krum, H.; Pillay, P. 1998: New drugs, old drugs. Beta-adrenoceptor blocking agents Medical Journal of Australia 168(5): 232-235
Manna, F.; Bolasco, A.; Bizzarri, B.; Lena, R.; Chimenti, F.; Filippelli, A.; Palla, A.; Fontana, M. 1996: Synthesis and beta-adrenoreceptor blocking activity of [[3-(alkylamine)-2-hydroxypropyl]oximino]pyridines and O[3-(alkylamine)-2-hydroxypropyl]methylpyridine ketone oximes derivatives Farmaco 51(8-9): 579-587
Slawin, S. 1973: Beta adrenergic blocking drugs Harefuah 85(4): 178-183
Lorimer, A.R.; Jones, J.V.; Clark, B.; Dunn, F.G.; Melville, D.; Lawrie, T.D. 1976: Indications for beta-adrenoceptor blocking drugs in hypertension Postgraduate Medical Journal 52(Suppl 4): 81-85
Walters, L.; Dormehl, I.; Goosen, D.J.; Avenant, J.C.; Du Plessis, M.; Jacobs, N.; Schoeman, H.S. 1983: Beta-adrenergic blocking drugs and renal function South African Medical Journal 64(15): 572-573
Balant, L.; Gorgia, A.; Tschopp, J.M.; Revillard, C.; Fabre, J. 1976: Pharmacokinetics of two beta blocking drugs: detection of a pharmacogenetic abnormality Schweizerische Medizinische Wochenschrift 106(41): 1403-1407
Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Gettes, L.S. 1970: Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias Cardiovascular Clinics 2(2): 211-237
Giardina, F.; Bellotti, G.; De Gregori, M.E.; Ghidini, O. 1971: The beta-blocking drugs in hyperthyroidism. 3. Effects on the post-thyroidectomy course and on the thyrotoxic crisis Minerva Medica 62(26): 1383-1392
Wayne, V.S.; Harper, R.W.; Laufer, E.; Federman, J.; Anderson, S.T.; Pitt, A. 1982: Adverse interaction between beta-adrenergic blocking drugs and verapamil--report of three cases Australian and New Zealand Journal of Medicine 12(4): 285-289
Mills, T.A.; Kawji, M.M.; Cataldo, V.D.; Pappas, N.D.; O'Meallie, L.P.; Breaux, D.M.; Glancy, D.L. 2004: Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 156(6): 327-331
Duan, H.J.; Fang, H.J.; Zhou, T.H.; Chen, C. 1991: Studies on the analysis of beta-blocking agents Yao Xue Xue Bao 26(5): 351-357
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Hellenbrecht, D.; Enenkel, J. 1984: Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat Arzneimittel-Forschung 34(9): 980-983
Merin, R.G. 1972: Anesthetic management problems posed by therapeutic advances: 3. Beta-adrenergic blocking drugs Anesthesia and Analgesia 51(4): 617-624